Get the latest Science News and Discoveries

Georgetown investigator presents final PAPILLON trial results showing long-term survival in a subset of lung cancer

None

Related news:

AI tool successfully predicts outcomes of immunotherapy in lung cancer

In the PAPILLON study, first-line amivantamab-chemotherapy demonstrates the longest overall survival reported for EGFR exon 20 insertion-positive advanced NSCLC

Vitamin B2 and Tumor Bacteria May Unlock a New Way To Fight Lung Cancer

« Fuel Savings Double Potential Lifetime for NASA’s Roman Mission - NASA Science

A Material Just a Few Atoms Thick Reveals Strange New Magnetism »